SCAI Multisociety Position Statement Addresses Occupational Health Hazards in Catheterization Labs
February 11, 2020—The Society for Cardiovascular Angiography & Interventions (SCAI) multisociety position statement on occupational health hazards of the catheterization laboratory has been published by Lloyd W. Klein, MD, et al online in SCAI’s Catheterization & Cardiovascular Interventions.
Philips’ DEFINE GPS Trial Will Assess Outcomes of PCI Guided by an Integrated Platform of iFR and Angiogram
February 11, 2020—Royal Philips announced a new randomized controlled trial to assess patient outcomes after receiving percutaneous coronary intervention (PCI) guided by Philips’ coregistration platform (which combines data of instant wave-free ratio (iFR) measurement and angiography) compared with the standard of care treatment guided by angiography alone.
Study Validates FFR-Guided PCI in Patients With Acute Coronary Syndrome
November 29, 2019—Findings from a study evaluating the use of fractional flow reserve (FFR) assessment in acute coronary syndrome (ACS) were published by Jad Omran, MD, et al online ahead of print in Catheterization & Cardiovascular Interventions.
Five-Year IVUS-XPL Outcomes Support Intravascular Ultrasound-Guided EES Implantation
September 29, 2019—The 5-year follow-up results of the IVUS-XPL randomized trial were published online by Sung-Jin Hong, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions simultaneously with their presentation in a late-breaking trial session at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium held September 25–29 in San Francisco, California.
Single-Center FORZA Trial Compares FFR and OCT Guidance for PCI
September 29, 2019—Findings from the FORZA trial were presented by Francesco Burzotta, MD, in a late-breaking trials session at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium held September 25–29 in San Francisco, California.
FDA Clears Siemens Healthineers' Artis icono Family of Angiography Systems
September 16, 2019—Siemens Healthineers announced FDA clearance for the Artis icono family of high-precision angiography systems that permit a wide range of minimally invasive procedures to be performed in a single interventional suite.
Canon Medical's Alphenix 4D CT System Introduced in the United States
July 22, 2019—Canon Medical Systems USA, Inc. announced the introduction of its Alphenix four-dimensional (4D) CT system with the first commercial installation at West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia.
Bayer's Gadavist Injection Contrast Agent Approved for Use in Cardiac MR in CAD Patients
July 15, 2019—Bayer announced that the FDA has approved an expanded indication for the company’s Gadavist (gadobutrol) injection for use in cardiac MR to assess myocardial perfusion and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).
Findings Presented for 2-Year Follow-Up Analysis of FFR-SEARCH Registry
June 20, 2019—Acist Medical Systems, Inc. announced that results of the 2-year follow-up analysis of the FFR-SEARCH observational registry were presented by Roberto Diletti, MD, during the EuroPCR conference held May 21–24 in Paris, France.
Study Supports IVUS-Guided PCI for Complex Coronary Lesions
April 2, 2019—Among patients with complex coronary artery lesion, percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS) was associated with lower long-term risk of cardiac death and adverse cardiac events compared with angiography-guided PCI; therefore, IVUS guidance should be actively considered for complex PCI, concluded Ki Hong Choi, MD, et al in findings from a study published in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2019;12:607–620).
Postapproval Study Supports Safety and Efficacy of CardioMEMS Sensor
March 17, 2019—The American College of Cardiology (ACC) announced that findings from the postapproval study for the CardioMEMS heart failure sensor (Abbott Vascular) were presented by David Shavelle, MD, at the ACC's 68th Annual Scientific Session, being held March 16–18 in New Orleans, Louisiana.
Use of Echocardiography Studied in Patient Selection for TMVR
March 17, 2019—The American College of Cardiology (ACC) announced the presentation of a study suggesting that clinicians should utilize echocardiography when determining whether patients with heart failure and secondary mitral regurgitation are likely to benefit from valve repair.
ADVANCE Study Supports HeartFlow Analysis to Identify Lower-Risk Patients
March 17, 2019—HeartFlow, Inc. announced that results from the ADVANCE trial of the HeartFlow fractional flow reserve computed tomography (FFRct) analysis technology were presented at the ACC's 68th Annual Scientific Session, being held March 16–18 in New Orleans, Louisiana.
DEFINE PCI Study Assesses Philips' iFR Guidance Technology
March 17, 2019—Royal Philips announced that results of the DEFINE PCI study, which assessed the level of residual ischemia found in patients after percutaneous coronary interventions (PCI), were presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session, being held March 16–18 in New Orleans, Louisiana.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.